Delivery Order SPE2DB20D2014-SPE2DB24FB23B
Award Date 3/5/24
Potential Completion Date 3/6/24
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide XELJANZ XR 11 MG TABLET UU 30S. This $1,879.09 contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. The company holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XELJANZ XR 11 mg tablets. The potential value of this delivery order is $3,014.72 and the period of performance extends through February 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide XELJANZ XR 11 MG tablets. The $5,121.37 order has a completion date of February 23, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside program. Additionally, AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,522.05 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide XELJANZ XR 11 MG TABLET UU 30S. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025 that enables Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $9,916.28 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XELJANZ XR 11 MG TABLET UU 30S. This order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation, to provide XELJANZ XR 11 MG TABLET medication. The $3,291.07 contract has a performance period through March 27, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $5,239.68 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of XELJANZ XR 11 MG TABLET 30S. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp by DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, is a firm fixed price delivery order for the supply of the medication XELJANZ XR 11 MG TABLET in 30-count packages. The contract, with a ceiling value of $8,490.08, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of March 20, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $4,263.36 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide XELJANZ 5 MG TABLET UU 60S. This delivery order contract has a completion date of February 7, 2024 and was awarded on February 6, 2024. Amerisourcebergen Drug Corp also holds a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a $45,168.10 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of XELJANZ XR 11 MG TABLET UU 30S. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...